Clinically Bharat

We Can Cover You

Submit Here
Facebook-f Linkedin-in Instagram Youtube
Menu

Dr Reddy’s Q3 PAT rises 2% despite 16% jump in revenues

BY-Creativebharatgroup@gmail.com January 23, 2025

Dr Reddy’s Q3 profit up 2% at Rs 1,413 crore; revenue at Rs 8,359 crore

BY-Creativebharatgroup@gmail.com January 23, 2025
Healthcare

Dr Reddy’s gets inspection report from USFDA for Srikakulam-based API plant, ET HealthWorld

BY-Creativebharatgroup@gmail.com September 6, 2024
Corporates

Dr Reddy’s gets USFDA’s inspection report for Srikakulam-based API plant | Company News

BY-Creativebharatgroup@gmail.com September 6, 2024
Corporates

Dr Reddy’s, Lupin recall products in US due to manufacturing issues: USFDA | Company News

BY-Creativebharatgroup@gmail.com September 4, 2024
Healthcare

Dr Reddy’s, Lupin recall products in US due to manufacturing issues, ET HealthWorld

BY-Creativebharatgroup@gmail.com September 4, 2024